IN BRIEF: TruSpine says subscription funds not received from Evrensel

TruSpine Technologies PLC - medical device company - Says Evrensel Capital Partners Ltd, which ...

Alliance News 6 April, 2021 | 6:09PM
Email Form Facebook Twitter LinkedIn RSS

TruSpine Technologies PLC - medical device company - Says Evrensel Capital Partners Ltd, which committed to subscribe in September 2020 for 694,444 new shares in TruSpine at a price of 36p per shares, raising gross proceeds of GBP250,000, has not provided funds due to TruSpine and is therefore in default on its commitment. The company says it has passed the matter on to its legal advisers.

Current stock price: 7.30 pence

By Evelina Grecenko; evelinagrecenko@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

Email Form Facebook Twitter LinkedIn RSS

Securities Mentioned in Article

Security Name Price Change (%) Morningstar
Rating
TruSpine Technologies PLC Ordinary Shares 0.55 -

About Author

Alliance News

Alliance News provides Morningstar with continuously updating coverage of news affecting listed companies.

© Copyright 2024 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures